Repligen | RGEN - مصاريف البيع والإدارة

سعر السهم
114.20
التغيير اليومي
0.44 0.39%
شهريا
-15.66%
سنويا
-24.18%
Q1 التوقعات
110.75




مصاريف البيع والإدارة تغيير تاريخ
Agilent USD 476M 48M 2025-12
Align Technology USD 441.68M 23.88M 2025-12
Bio Techne USD 113.69M 2.52M 2025-12
BioMarin Pharmaceutical USD 322.21M 98.79M 2025-12
Bristol-Myers Squibb USD 2.18B 392M 2025-12
Bruker USD 247.2M 4.7M 2025-12
Charles River Laboratories USD 196.14M 18.55M 2025-12
Danaher USD 2.03B 35M 2025-12
Dentsply International USD 383M 28M 2025-12
Exact Sciences USD 491.64M 35.94M 2025-09
General Electric Aerospace USD 1.58B 385M 2025-12
Henry Schein USD 808M 48M 2025-12
Illumina USD 283M 27M 2025-12
IQVIA Holdings USD 468M 46M 2025-12
Mettler Toledo International USD 259.83M 11.43M 2025-12
Myriad Genetics USD 129M 1.3M 2025-09
OraSure Technologies USD -0.06 0.05 2024-09
Pacific Biosciences Of California USD 43.75M 2.13M 2024-09
Pfizer USD 4.08B 894M 2025-12
Repligen USD 74.36M 703K 2025-12
Revvity USD 251.73M 9.82M 2025-12
Standard Biotools USD 26.6M 1.5M 2025-09
Thermo Fisher Scientific USD 1.98B 182M 2025-12
Waters USD 240.01M 25.78M 2025-12
West Pharmaceutical Services USD 106.5M 3.8M 2025-12